HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New Elite Feature: Screen & Chart at the same time

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

Insight Molecular Diagnostics Inc.

Contributing Author

Recent Articles by Insight Molecular Diagnostics Inc.

May-13
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization IMDX +25.88% IMDX GlobeNewswire
May-06
iMDx to Release First Quarter 2026 Results on May 13, 2026 IMDX +9.83% GlobeNewswire
Apr-14
Real-World Evidence and Industry Momentum Builds for iMDx's Flagship GraftAssure Assay IMDX +20.33% GlobeNewswire
Mar-26
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results IMDX -13.38% IMDX GlobeNewswire
Mar-20
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference IMDX +8.67% GlobeNewswire
Mar-13
Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score IMDX GlobeNewswire
Mar-03
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission IMDX +10.32% GlobeNewswire
Feb-11
iMDx Announces $26.0 Million Registered Direct Offering IMDX -22.67% GlobeNewswire
Jan-13
IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring IMDX GlobeNewswire
Jan-07
iMDx Announces "JPM Week" and "BTIG Snowbird" Conference Participation IMDX GlobeNewswire
Jan-06
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch IMDX GlobeNewswire
Jan-05
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion IMDX GlobeNewswire
Nov-10
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch IMDX +10.66% IMDX +8.97% GlobeNewswire
Nov-03
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week IMDX GlobeNewswire
Oct-13
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch IMDX GlobeNewswire
Oct-06
iMDx Reports Kidney Transplant Patient Achieved 'Immune Reset' with Novel Therapy and GraftAssure Monitoring IMDX GlobeNewswire
Sep-24
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando IMDX +8.80% GlobeNewswire
Sep-08
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database IMDX GlobeNewswire
Sep-08
IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants IMDX GlobeNewswire
Aug-26
iMDx to Participate in NYC Investment Conferences September 8 - 11 IMDX GlobeNewswire
Aug-11
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch IMDX GlobeNewswire
Aug-04
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference IMDX +8.20% IMDX -5.78% GlobeNewswire
Jul-30
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients IMDX -6.67% IMDX GlobeNewswire
Jul-28
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025 IMDX GlobeNewswire
Jun-23
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing IMDX -13.68% IMDX -5.74% GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)